Learn about CJC 1295 peptide supplements that aim to reshape how men can approach muscle building, recovery, and growth ...

A small group of volunteers will receive multiple injections of the experimental treatments next month, says Unlimited Bio.

Modern weight loss treatments have transformed how we approach obesity management, but they come with concerning side effects. The growing use of glucagon-like peptide-1 medications has highlighted an ...

A combination treatment of semaglutide, trevogrumad and garetosmab causes fat loss and muscle growth in primate trials. Full trial results for humans are expected later in 2025. Results from the Phase ...

(Reuters) -Treatments designed to help patients preserve muscle while losing weight with popular obesity drugs by Eli Lilly and Novo Nordisk could generate more than $30 billion in sales by 2035, ...

In the world of fitness and bodybuilding, finding the right supplement can be the key to achieving your goals. Dyno Myo-Grow is making waves as a natural anabolic alternative that promises significant ...

Thinking about taking Ozempic but worried about losing too much muscle? New clinical trial data might point to a future where that’s no longer a concern. Regeneron Pharmaceuticals announced the ...

An experimental oral drug claims to do the work of medications like GLP-1s without losing muscle mass.

(Bloomberg) -- Eli Lilly & Co. halted a study of an experimental drug designed to prevent obesity patients from losing too much muscle, citing strategic business reasons it didn’t disclose. Lilly ...

Cancer patients often lose excessive amounts of weight. This affects up to 80% of patients and is mainly due to a decrease in ...

June 20 (Reuters) - Treatments designed to help patients preserve muscle while losing weight with popular obesity drugs by Eli Lilly (LLY.N), opens new tab and Novo Nordisk (NOVOb.CO), opens new tab ...